Diabetic Neuropathies - Drug therapy
Research News and Information

Monday, November 23, 2009

Ghrelin reverses experimental diabetic neuropathy in mice.

Sep 2009 Ghrelin, an acylated peptide produced in the stomach, increases food intake and growth hormone secretion, suppresses inflammation and oxidative stress, and promotes cell survival and proliferation. We investigated the pharmacological potential of ... Read more...

Continuous buprenorphine delivery effect in streptozotocine-induced painful diabetic neuropathy in rats.

30 Aug 2009 Diabetic peripheral neuropathy (DPN) can induce loss of nociception as well as mechanical hyperalgesia and tactile allodynia. Pharmacological and clinical studies have shown that buprenorphine, a low-molecular-weight, lipophilic, opioid analgesic ... Read more...

Diabetic neuropathy: therapies on the horizon.

30 Aug 2009 OBJECTIVES: This is a review of emerging interventions from the recent preclinical and clinical literature that demonstrate the potential for effectiveness in the therapy of diabetic neuropathy (DN). DN is the most common complication of diabetes ... Read more...

Latest indexed articles for 'Diabetic Neuropathies - Drug therapy'

These are the very latest articles for this heading:

• Ghrelin reverses experimental diabetic neuropathy in mice. Sep 2009
• Continuous buprenorphine delivery effect in streptozotocine-induced painful diabetic neuropathy in rats. 30 Aug 2009
• Diabetic neuropathy: therapies on the horizon. 30 Aug 2009
• Pregabalin for acute and chronic pain in adults. 6 Jul 2009
• [Diabetic peripheral neuropathy: reflections and drug-rehabilitative treatment] 29 Jun 2009
• Effects of angiotensin II receptor blockers on diabetic nephropathy. 29 Jun 2009
• Demonstration of antiallodynic effects of the cyclooxygenase-2 inhibitor meloxicam on established diabetic neuropathic pain in mice. 3 Jun 2009
• Advances in the management of diabetic peripheral neuropathy. 30 May 2009
• Efficacy and safety of lacosamide in diabetic neuropathic pain: an 18-week double-blind placebo-controlled trial of fixed-dose regimens. 30 May 2009
• [Also elderly with polyneuropathic pain should get chance to pain relief] 30 May 2009
• Treatment of symptomatic polyneuropathy with actovegin in type 2 diabetic patients. 24 May 2009
• Lacosamide in painful diabetic neuropathy: an 18-week double-blind placebo-controlled trial. 3 May 2009
• Using botulinum toxin to treat diabetic foot pain. 26 Apr 2009
• B vitamins alleviate indices of neuropathic pain in diabetic rats. 21 Apr 2009
• Ranirestat for the management of diabetic sensorimotor polyneuropathy. 12 Apr 2009
• [Progress in therapy for and diagnosis of diabetic neuropathies] 8 Apr 2009
• The effects of short-term, rapid glycemic control on the peroneal nerve function and serum VCAM-1 and AGE in type 2 diabetic patients in Malaysia. 30 Mar 2009
• A simple two-stage design for quantitative responses with application to a study in diabetic neuropathic pain. 30 Mar 2009
• Cellular and physiological effects of C-peptide. 30 Mar 2009
• Botulinum toxin for neuropathic pain? 23 Mar 2009

See a longer list of these articles.

Technical information about 'Diabetic Neuropathies'

Definition: Peripheral, autonomic, and cranial nerve disorders that are associated with DIABETES MELLITUS. These conditions usually result from diabetic microvascular injury involving small blood vessels that supply nerves (VASA NERVORUM). Relatively common conditions which may be associated with diabetic neuropathy include third nerve palsy (see OCULOMOTOR NERVE DISEASES); MONONEUROPATHY; mononeuropathy multiplex; diabetic amyotrophy; a painful POLYNEUROPATHY; autonomic neuropathy; and thoracoabdominal neuropathy. (From Adams et al., Principles of Neurology, 6th ed, p1325)

Descriptor UI: D003929

Alternative terms: Diabetic Neuropathies; Diabetic Neuropathy; Neuropathies, Diabetic; Neuropathy, Diabetic; Diabetic Polyneuropathy; Diabetic Polyneuropathies; Polyneuropathies, Diabetic; Polyneuropathy, Diabetic; Asymmetric Diabetic Proximal Motor Neuropathy; Diabetic Asymmetric Polyneuropathy; Asymmetric Polyneuropathies, Diabetic; Asymmetric Polyneuropathy, Diabetic; Diabetic Asymmetric Polyneuropathies; Polyneuropathies, Diabetic Asymmetric; Polyneuropathy, Diabetic Asymmetric; Diabetic Autonomic Neuropathy; Autonomic Neuropathies, Diabetic; Autonomic Neuropathy, Diabetic; Diabetic Autonomic Neuropathies; Neuropathies, Diabetic Autonomic; Neuropathy, Diabetic Autonomic; Symmetric Diabetic Proximal Motor Neuropathy; Diabetic Amyotrophy; Amyotrophies, Diabetic; Amyotrophy, Diabetic; Diabetic Amyotrophies; Diabetic Neuralgia; Diabetic Neuralgias; Neuralgias, Diabetic; Diabetic Neuropathy, Painful; Diabetic Neuropathies, Painful; Neuropathies, Painful Diabetic; Neuropathy, Painful Diabetic; Painful Diabetic Neuropathies; Painful Diabetic Neuropathy; Neuralgia, Diabetic; Diabetic Mononeuropathy; Diabetic Mononeuropathies; Mononeuropathies, Diabetic; Mononeuropathy, Diabetic; Diabetic Mononeuropathy Simplex; Diabetic Mononeuropathy Simplices; Mononeuropathy Simplex, Diabetic; Mononeuropathy Simplices, Diabetic; Simplex, Diabetic Mononeuropathy; Simplices, Diabetic Mononeuropathy;

Allowable Qualifiers: blood; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; surgery; therapy; urine; veterinary; ultrasonography; virology;

Tree Number: C10.668.829.300; C19.246.099.937;

Technical Notes: coord IM with specific neurol dis (IM) but do not coord with PERIPHERAL NERVOUS SYSTEM DISEASES for "diabetic peripheral neuropathy"